Researchers create nanoparticle that crosses blood-brain barrier

Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami have developed a nanoparticle that can cross the blood-brain barrier, potentially opening the door for new treatments for brain metastases.

The nanoparticle is made of a biodegradable polymer that is loaded with two prodrugs that target cancer cells' mitochondrial DNA, according to a May 6 article on the university's website. One is a modified form of common chemotherapy drug cisplatin. The second is a drug researchers developed in the lab known as Mito-DCA.

In preclinical trials, the drug-loaded nanoparticle shrunk both breast tumors and breast cancer cells in the brain. The research was published May 6 in Proceedings of the National Academy of Sciences.

Researchers said they are still working to understand how these nanoparticles cross the blood-brain barrier and that more preclinical research is needed. 

Learn more here.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like